Literature DB >> 27046277

Multifacet assessment of capability for suicide: Development and prospective validation of the Acquired Capability With Rehearsal for Suicide Scale.

Sarah E George1, Andrew C Page1, Geoffrey R Hooke1, Werner G K Stritzke1.   

Abstract

The interpersonal theory of suicide proposes that acquired capability facilitates transformation of suicidal desire into lethal self-destructive behavior (Joiner, 2005). A new measure, the Acquired Capability With Rehearsal for Suicide Scale (ACWRSS), was devised to capture the key facets of acquired capability-pain tolerance and fearlessness of death-while also incorporating deliberate and active means to increase preparedness for suicide. The factor structure of the ACWRSS was tested using confirmatory factor analysis (n = 611). The 7-item ACWRSS conformed to the hypothesized 3-factor structure, demonstrating excellent fit and good internal consistency (α = .83). Measurement invariance across gender was also demonstrated on configural, metric, and scalar levels. Next, in the first longitudinal study of the association between acquired capability and suicide ideation, intention, and readiness (n = 234), the acquired capability facets prospectively predicted specific phases in the motivational-volitional pathway toward suicide readiness. Moreover, 2 of the acquired capability components mediated the relationship between baseline nonsuicidal self-injury and suicide readiness at follow-up. In an inpatient psychiatric sample (n = 108), the ACWRSS was significantly correlated with prior suicide attempts and thoughts and episodes of nonsuicidal self-injury, and its facets demonstrated differential sensitivity to change. The ACWRSS is the first measure of acquired capability that reliably and validly captures all key facets of this critical component of the interpersonal theory of suicide. Its brevity enhances its utility for both research and clinical settings. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27046277     DOI: 10.1037/pas0000276

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  7 in total

Review 1.  From ideation to action: recent advances in understanding suicide capability.

Authors:  Alexis M May; Sarah E Victor
Journal:  Curr Opin Psychol       Date:  2017-07-14

2.  The relevance of the interpersonal theory of suicide for predicting past-year and lifetime suicidality in autistic adults.

Authors:  R L Moseley; N J Gregory; P Smith; C Allison; S Cassidy; S Baron-Cohen
Journal:  Mol Autism       Date:  2022-03-21       Impact factor: 6.476

Review 3.  The interpersonal theory of suicide: A systematic review and meta-analysis of a decade of cross-national research.

Authors:  Carol Chu; Jennifer M Buchman-Schmitt; Ian H Stanley; Melanie A Hom; Raymond P Tucker; Christopher R Hagan; Megan L Rogers; Matthew C Podlogar; Bruno Chiurliza; Fallon B Ringer; Matthew S Michaels; Connor H G Patros; Thomas E Joiner
Journal:  Psychol Bull       Date:  2017-10-26       Impact factor: 17.737

4.  Tolerance for psychological pain and capability for suicide: Contributions to suicidal ideation and behavior.

Authors:  Esther L Meerwijk; Sandra J Weiss
Journal:  Psychiatry Res       Date:  2018-02-03       Impact factor: 3.222

5.  Examining the temporal stability of suicide capability among undergraduates: A latent growth analysis.

Authors:  Kaitlyn R Schuler; Phillip N Smith; Katrina A Rufino; Gregory L Stuart; Caitlin Wolford-Clevenger
Journal:  J Affect Disord       Date:  2020-12-29       Impact factor: 4.839

6.  Links between self-injury and suicidality in autism.

Authors:  R L Moseley; N J Gregory; P Smith; C Allison; S Baron-Cohen
Journal:  Mol Autism       Date:  2020-02-10       Impact factor: 7.509

7.  Validation of the German capability for suicide questionnaire (GCSQ) in a high-risk sample of suicidal inpatients.

Authors:  Jan C Cwik; Thomas Forkmann; Heide Glaesmer; Laura Paashaus; Antje Schönfelder; Dajana Rath; Sarah Prinz; Georg Juckel; Tobias Teismann
Journal:  BMC Psychiatry       Date:  2020-08-20       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.